Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Regeneron posts phase 3 win, advancing push to muscle in on gMG
Regeneron plans to file for FDA approval of its siRNA candidate in the increasingly competitive generalized myasthenia gravis market.
Nick Paul Taylor
Aug 26, 2025 9:41am
Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients
Aug 26, 2025 6:45am
PDS reports 39 months OS in phase 2 head and neck cancer trial
Aug 25, 2025 9:00am
Viking hits stormy seas as phase 2 oral obesity data sink stock
Aug 19, 2025 9:44am
Response's ex-Sanofi asset hits goal in post-GLP-1 patients
Aug 13, 2025 9:14am
Trinity Biotech says its 15-day CGM works without fingersticks
Aug 12, 2025 12:30pm